Filing Details
- Accession Number:
- 0001209191-13-053775
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-22 16:20:59
- Reporting Period:
- 2013-11-20
- Filing Date:
- 2013-11-22
- Accepted Time:
- 2013-11-22 16:20:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1254419 | Medassets Inc | MDAS | Services-Prepackaged Software (7372) | 510391128 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1058190 | F Bruce Wesson | 100 North Point Center East Suite 200 Alpharetta GA 30022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-20 | 18,890 | $9.29 | 109,021 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-20 | 12,779 | $9.68 | 121,800 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-20 | 2,223 | $2.86 | 124,023 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-20 | 20,001 | $2.86 | 144,024 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-20 | 6,370 | $0.00 | 150,394 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-20 | 53,893 | $20.54 | 96,501 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-20 | 6,369 | $20.58 | 90,132 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-21 | 1 | $20.82 | 90,131 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2013-11-20 | 20,001 | $0.00 | 20,001 | $2.86 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2013-11-20 | 12,779 | $0.00 | 12,779 | $9.68 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2013-11-20 | 18,890 | $0.00 | 18,890 | $9.29 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2013-11-20 | 2,223 | $0.00 | 2,223 | $2.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-09-01 | No | 4 | M | Direct | |
| 0 | 2016-10-05 | No | 4 | M | Direct | |
| 0 | 2017-09-10 | No | 4 | M | Direct | |
| 0 | 2015-02-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Restricted Stock | 5,168 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | $15.95 | 2018-03-25 | 4,966 | 4,966 | Direct | |
| Common Stock | Stock-Settled Stock Appreciation Rights | $21.27 | 2017-01-15 | 16,704 | 16,704 | Direct | |
| Common Stock | Stock-Settled Stock Appreciation Rights | $16.04 | 2018-05-09 | 18,242 | 18,242 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2018-03-25 | 4,966 | 4,966 | Direct |
| 2017-01-15 | 16,704 | 16,704 | Direct |
| 2018-05-09 | 18,242 | 18,242 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.51 to $20.58, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.55 to $20.66, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
- The reporting person was granted these stock options on August 1, 2005 and are fully vested.
- The reporting person was granted these stock options on October 1, 2006 and are fully vested.
- The reporting person was granted these stock options on September 10, 2007 and are fully vested.
- The reporting person was granted these stock options on February 3, 2005 and are fully vested.
- The reporting person was granted these stock options on March 25, 2008 and are fully vested.
- The reporting person was granted these stock-settled stock appreciation rights (SSARs) on January 15, 2010 and are fully vested.
- The reporting person was granted these SSARs on May 9, 2011 and are fully vested.
Billionaire Hedge Funds
